vimarsana.com
Home
Live Updates
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial | Coronavirus (COVID-19) | JAMA : vimarsana.com
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial | Coronavirus (COVID-19) | JAMA
This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v
Related Keywords
Canada ,
Delaware ,
United States ,
Shawa ,
Shanxi ,
China ,
Helsinki ,
Eteläuomen Läi ,
Finland ,
America ,
Chinese ,
Junshi Biosciences ,
Bristol Myers Squibb ,
Danielm Skovronsky ,
Eli Lilly ,
Monte Carlo ,
Van Naarden ,
David Mcilwain ,
Abcellera Biologics ,
Morris ,
Pfizer ,
Drug Administration ,
Johnson ,
Institute Inc ,
World Health Organization ,
Infectious Diseases Vaccine Research Center ,
Amgen ,
Gilead Sciences ,
Glaxosmithkline ,
National Institute Of Allergy ,
Emergency Use ,
North America ,
Blocking Viral Attachment ,
Cell Entry ,
International Conference ,
Harmonization Guidelines ,
Good Clinical Practice ,
Secondary Outcomes ,
Enterprise Guide ,
Clinical Characteristics ,
Hoc Analyses ,
Emergency Use Authorization ,
Drs Gottlieb ,
Interest Disclosures ,
Drs Nirula ,
Drs Oakley ,
Sharing Statement ,
National Institute ,
Infectious Diseases Vaccine Research ,
Chinese Academy ,
vimarsana.com © 2020. All Rights Reserved.